Apogee Therapeutics (APGE) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.22
-1.01
-0.8
-0.6

Details

Expected EPS
-1.21589
Actual EPS
-0.95
Surprise EPS
0.27
Surprise Percent
+21.87%

Description

Apogee Therapeutics (APGE) has reported earnings of -0.95 per share for Q2 2025.

0 Comments

Share your thoughts